HIMS

$27.686.71%-1.99

アフターアワーズ： 27.67-0.01 -0.04%

Hims Hers Health Inc (HIMS)

Date: O: H: L: C: Vol:

前日終値:

$29.67

開ける：

$28.51

24時間の取引高:

10,825,026

相対出来高:

1.26

時価総額：

$6.46B

収益：

$2.35B

当期純損益:

$128.37M

株価収益率:

53.02

EPS:

$0.5221

ネットキャッシュフロー:

$57.42M

1W パフォーマンス:

-0.11%

1M パフォーマンス:

-7.08%

6M パフォーマンス:

+1.88%

1Y パフォーマンス:

-37.18%

1日の値動き範囲:

$26.68$28.75

1週間の範囲:

$26.68$30.13

52週間の値動き範囲:

$13.74$48.34

Hims Hers Health Inc（HIMS）会社概要

名前

Hims Hers Health Inc

セクター

Healthcare

産業

Drug Manufacturers - Specialty & Generic

電話

415-851-0195

住所

2269 CHESTNUT ST, SAN FRANCISCO, USA

職員

2,442

次回の収益日

2026-11-09

最新のSEC提出書

SEC

XでのHIMSに関するディスカッション

HIMS と TAK, TEVA, HLN, ZTS, UTHR を比較

株式	価格	時価総額	収益	当期純利益	現金流量	EPS
HIMS Hims Hers Health Inc	$27.68	$6.46B	$2.35B	$128.37M	$57.42M	$0.5221
TAK Takeda Pharmaceutical Co Adr	$20.91	$66.81B	$29.91B	$1.30B	$3.49B	$0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	$42.09	$49.09B	$17.53B	$1.58B	$444.18M	$1.35
HLN Haleon Plc Adr	$8.66	$38.08B	$14.54B	$2.22B	$2.58B	$0.4871
ZTS Zoetis Inc	$79.72	$32.94B	$9.51B	$2.64B	$2.14B	$6.04
UTHR United Therapeutics Corp	$598.72	$25.68B	$3.17B	$1.29B	$1.01B	$27.09

Hims Hers Health Inc (HIMS) アップグレードとダウングレード

日付	アクション	アナリスト	評価の変更
2026-09-11	Resumed	JP Morgan	Neutral
2026-05-12	繰り返されました	Needham	Buy
2026-04-24	開始されました	JP Morgan	Overweight
2026-03-10	アップグレード	BofA Securities	Underperform → Neutral
2026-03-10	アップグレード	Citigroup	Sell → Neutral
2026-03-09	アップグレード	Needham	Hold → Buy
2026-02-24	ダウングレード	BTIG Research	Buy → Neutral
2026-01-12	開始されました	Evercore ISI	In-line
2025-12-09	開始されました	Barclays	Overweight
2025-10-21	開始されました	KeyBanc Capital Markets	Sector Weight
2025-06-23	ダウングレード	Needham	Buy → Hold
2025-06-04	繰り返されました	Needham	Buy
2025-04-29	ダウングレード	TD Cowen	Buy → Hold
2025-02-18	ダウングレード	Morgan Stanley	Overweight → Equal-Weight
2025-01-10	ダウングレード	Citigroup	Neutral → Sell
2025-01-07	開始されました	BTIG Research	Buy
2024-12-17	開始されました	Morgan Stanley	Overweight
2024-11-14	ダウングレード	BofA Securities	Buy → Underperform
2024-08-22	開始されました	Needham	Buy
2024-08-09	ダウングレード	Imperial Capital	Outperform → In-line
2024-05-22	ダウングレード	Citigroup	Buy → Neutral
2024-04-16	ダウングレード	Jefferies	Buy → Hold
2024-04-10	開始されました	Canaccord Genuity	Buy
2024-02-28	アップグレード	Imperial Capital	In-line → Outperform
2024-02-26	開始されました	Leerink Partners	Market Perform
2023-12-07	開始されました	Imperial Capital	In-line
2023-07-28	開始されました	TD Cowen	Outperform
2023-04-11	開始されました	Robert W. Baird	Neutral
2023-02-09	アップグレード	Jefferies	Hold → Buy
2022-11-08	アップグレード	BofA Securities	Neutral → Buy
2022-11-08	アップグレード	SVB Leerink	Mkt Perform → Outperform
2022-10-17	ダウングレード	Piper Sandler	Overweight → Neutral
2022-09-07	開始されました	Truist	Hold
2022-07-15	開始されました	SVB Leerink	Underperform
2022-04-14	開始されました	Guggenheim	Buy
2022-04-01	Resumed	Credit Suisse	Outperform
2022-03-10	開始されました	Deutsche Bank	Hold
2021-12-02	開始されました	Jefferies	Hold
2021-11-11	アップグレード	Piper Sandler	Neutral → Overweight
2021-07-06	開始されました	BofA Securities	Neutral
2021-05-20	アップグレード	Credit Suisse	Neutral → Outperform
2021-04-21	開始されました	Truist	Hold
2021-03-09	開始されました	Credit Suisse	Neutral
2021-03-02	アップグレード	Citigroup	Neutral → Buy
2021-02-17	開始されました	Citigroup	Neutral
2021-02-12	開始されました	Piper Sandler	Neutral
2021-02-08	開始されました	Tigress Financial	Buy

Hims Hers Health Inc (HIMS) 財務データ

収益

当期純利益

現金流量

EPS

Hims Hers Health Inc (HIMS) インサイダートレーディング

Boughton SoleilOct 28 '26
Officer
取引
Proposed Sale
コスト
$27.60
#株式
3,462
値 ($)
95,551
#株式総数
0
Boughton SoleilOct 14 '26
Chief Legal Officer
取引
Sale
コスト
$29.06
#株式
3,461
値 ($)
100,577
#株式総数
297,348
Boughton SoleilOct 14 '26
Officer
取引
Proposed Sale
コスト
$29.06
#株式
3,461
値 ($)
100,577
#株式総数
0
Okupe OluyemiOct 01 '26
Chief Financial Officer
取引
Sale
コスト
$29.70
#株式
2,000
値 ($)
59,400
#株式総数
234,527
Okupe OluyemiOct 01 '26
Officer
取引
Proposed Sale
コスト
$29.70
#株式
2,000
値 ($)
59,400
#株式総数
0
Boughton SoleilSep 30 '26
Officer
取引
Proposed Sale
コスト
$29.17
#株式
3,461
値 ($)
100,957
#株式総数
0
Boughton SoleilSep 30 '26
Chief Legal Officer
取引
Sale
コスト
$29.17
#株式
3,461
値 ($)
100,957
#株式総数
300,809
Okupe OluyemiSep 22 '26
Officer
取引
Proposed Sale
コスト
$29.95
#株式
29,277
値 ($)
876,846
#株式総数
0
Okupe OluyemiSep 22 '26
Chief Financial Officer
取引
Sale
コスト
$29.95
#株式
29,277
値 ($)
876,846
#株式総数
236,527
Okupe OluyemiSep 22 '26
Chief Financial Officer
取引
Option Exercise
コスト
$5.01
#株式
14,000
値 ($)
70,140
#株式総数
265,804

インサイダートレーディング	関係	日付	取引	コスト	#株式	値 ($)	#株式総数
Boughton Soleil	Officer	Oct 28 '26	Proposed Sale	$27.60	3,462	95,551	0
Boughton Soleil	Chief Legal Officer	Oct 14 '26	Sale	$29.06	3,461	100,577	297,348
Boughton Soleil	Officer	Oct 14 '26	Proposed Sale	$29.06	3,461	100,577	0
Okupe Oluyemi	Chief Financial Officer	Oct 01 '26	Sale	$29.70	2,000	59,400	234,527
Okupe Oluyemi	Officer	Oct 01 '26	Proposed Sale	$29.70	2,000	59,400	0
Boughton Soleil	Officer	Sep 30 '26	Proposed Sale	$29.17	3,461	100,957	0
Boughton Soleil	Chief Legal Officer	Sep 30 '26	Sale	$29.17	3,461	100,957	300,809
Okupe Oluyemi	Officer	Sep 22 '26	Proposed Sale	$29.95	29,277	876,846	0
Okupe Oluyemi	Chief Financial Officer	Sep 22 '26	Sale	$29.95	29,277	876,846	236,527
Okupe Oluyemi	Chief Financial Officer	Sep 22 '26	Option Exercise	$5.01	14,000	70,140	265,804

Hims Hers Health Inc (HIMS) 最新ニュース

Oct 29, 2026

Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.

Oct 29, 2026

Hims & Hers Health, Inc. (HIMS) Gains As Market Dips: What You Should Know - Zacks Investment Research

Oct 29, 2026

Oct 28, 2026

HIMS 5-DAY DEADLINE ALERT: Hims & Hers Health Investors with Significant Losses Encouraged to Contact Hagens Berman Before Nov. 2, 2026 Deadline in Securities Class Action - GlobeNewswire Inc.

Oct 28, 2026

Oct 27, 2026

What Are Hims & Hers Health Stock Investors Overlooking? - Trefis

Oct 27, 2026

Oct 26, 2026

Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.

Oct 26, 2026

Deadline Alert: Hims & Hers Health, Inc. Investors Have - GlobeNewswire

Oct 26, 2026

HIMS 1-WEEK DEADLINE ALERT: Hims & Hers Health Investors with Significant Losses Encouraged to Contact Hagens Berman Before Nov. 2, 2026 Deadline in Securities Class Action - PR Newswire

Oct 26, 2026

Oct 25, 2026

INV DEADLINE NOTICE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Innventure, Inc. Investors to Secure Counsel Before Important October 27 Deadline in Securities Class Action - INV - GlobeNewswire Inc.

Oct 25, 2026

FTK DEADLINE NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Flotek Industries, Inc. Investors to Secure Counsel Before Important October 26 Deadline in Securities Class Action - FTK - GlobeNewswire Inc.

Oct 25, 2026

HIMS FINAL DEADLINE: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important November 2 Deadline in Securities Class Action - HIMS - GlobeNewswire Inc.

Oct 25, 2026

Hims & Hers Health (HIMS) Alert: Securities Class Action Pending, Investors with Losses Encouraged to Contact Hagens Berman Before November 2, 2026 Lead Plaintiff Deadline - GlobeNewswire Inc.

Oct 25, 2026

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Millrose Properties, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRP - GlobeNewswire Inc.

Oct 25, 2026

Oct 23, 2026

Hims & Hers Health Inc (HIMS) Stock Down 4.9% -- Now Undervalued? GF Score: 75/100 - GuruFocus

Oct 23, 2026

Hims & Hers Health, Inc. (HIMS) Declines More Than Market: Some Information for Investors - Yahoo Finance

Oct 23, 2026

Hims & Hers Health, Inc. (HIMS) Declines More Than Market: Some Information for Investors - Zacks Investment Research

Oct 23, 2026

Hims & Hers Defends Subscription Practices And Privacy Disclosures Against Lawsuit - Benzinga

Oct 23, 2026

Oct 22, 2026

Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.

Oct 22, 2026

Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - Carroll County Mirror-Democrat

Oct 22, 2026

Hims & Hers Health, Inc. Tokenized Stock (Coinbase) price today, HIMSc to USD live price, marketcap and chart - CoinMarketCap

Oct 22, 2026

Hims & Hers Health (HIMS) Facing Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower - The National Law Review

Oct 22, 2026

Hims Seeks Dismissal of FTC Suit Over User Data, Subscriptions - Bloomberg.com

Oct 22, 2026

Oct 21, 2026

Hims & Hers Health, Inc. (HIMS) Stock Forecasts - Yahoo Finance

Oct 21, 2026

A New Era for Testosterone Care: Hims Launches New Injectable and Oral TRT Options - Hims & Hers Newsroom

Oct 21, 2026

Hims Expands Testosterone Care with Injectable and Oral TRT, Its Largest Men’s Health Launch to Date - HIMS investor relations

Oct 21, 2026

Oct 20, 2026

Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC - GlobeNewswire Inc.

Oct 20, 2026

Bragar Eagel & Squire, P.C. Reminds Hims & Hers Health, Inc. Investors of the Upcoming Lead Plaintiff Deadline and Urges Investors to Contact the Firm Before November 2nd - GlobeNewswire Inc.

Oct 20, 2026

Hims & Hers Health Inc (HIMS) Shares Surge 3.8% -- What GF Score of 75 Tells Investors - GuruFocus

Oct 20, 2026

Hims & Hers Gains as It Launches Men’s Weight-Loss Care in Germany - Yahoo Finance

Oct 20, 2026

Hims & Hers Health Jumps 6.2% Amid Sector-Wide Rally - AlphaStreet

Oct 20, 2026

What's Next for Hims & Hers Health, Inc. Shareholders After 14.73% Stock Drop? Glancy Prongay Wolke & Rotter LLP Explains Securities Fraud Class Action Lead Plaintiff Deadline - Morningstar

Oct 20, 2026

Hims & Hers gains after German launch - Seeking Alpha

Oct 20, 2026

Hims & Hers Health launches online weight management service for men in Germany - Reuters

Oct 20, 2026

Hims & Hers Health launches online weight management service for men in Germany - Yahoo Finance Singapore

Oct 20, 2026

Oct 19, 2026

Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.

Oct 19, 2026

Hims Is Reaching the Three Million Member Milestone - The Motley Fool

Oct 19, 2026

HIMS DEADLINE: ROSEN, LEADING INVESTOR RIGHTS COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important November 2 Deadline in Securities Class Action - HIMS - GlobeNewswire Inc.

Oct 19, 2026

What Are Hims & Hers Health Stock Bears Missing? - Trefis

Oct 19, 2026

Hims & Hers Health: The Lollapalooza Effect Of GLP-1s (NYSE:HIMS) - Seeking Alpha

Oct 19, 2026

Oct 16, 2026

Hims & Hers Health Inc (HIMS) Stock Down 4.5% -- Now Undervalued? GF Score: 75/100 - GuruFocus

Oct 16, 2026

ROSEN, LEADING INVESTOR COUNSEL, Encourages Millrose Properties, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRP - GlobeNewswire Inc.

Oct 16, 2026

HIMS DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HIMS - GlobeNewswire Inc.

Oct 16, 2026

What Does Hims & Hers Health (HIMS) Expansion Into The UK And Australia Mean? - Yahoo Finance

Oct 16, 2026

Hims & Hers Health (HIMS) Alert: Securities Class Action Filed, Investors with Losses Encouraged to Contact Hagens Berman Before November 2, 2026 Lead Plaintiff Deadline - PR Newswire

Oct 16, 2026

How Is Hims & Hers Health, Inc. (NYSE:HIMS) Reshaping Its Business? - Kalkine Media

Oct 16, 2026

Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know - Zacks Investment Research

Oct 16, 2026

Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

Oct 16, 2026

Oct 15, 2026

Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.

Oct 15, 2026

Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - The Killeen Daily Herald

Oct 15, 2026

Kaplan Fox & Kilsheimer LLP Encourages Hims & Hers Health, Inc - The National Law Review

Oct 15, 2026

Hims & Hers Health rises as HHS moves ahead with plan for compounding peptides - Seeking Alpha

Oct 15, 2026

HIMSに類似